Gapping up
In reaction to strong earnings/guidance:
- CRAY +12.5%, SFLY +10.7%, NANO +10.3%, SQNS +9.4%, ENPH +8.9%, ZEN +8.6%, LITE +8.3%, CYH +7.6%, EVTC +7.3%, MTSI +7.2%, BRKS +7.2%, JNPR +7.1%, FTR +6.4%, CRTO +5.5%, PBI +5.2%, MBUU +5%, AAPL +4.5%, NVO +4.5%, RRR +4.3%, ACTG +4.1%, CVS +4%, OZM +4%, LDL +3.9%, GRMN +3.8%, ADP +3.5%, ACHC +3.4%, CHK +3.4%, OCN +3.1%, DIN +3%, SODA +2.8%, TCP +2.7%, HCLP +2.5%, CBRE +2.4%, ABC +2.2%, INSM +2.2%, VOYA +2.1%, AMRN +2.1%, TDOC +2%, DVN +1.6%, GIB +1.6%, HRS +1.5%, GLUU +1.1%, WNC +1.1%, NI +1%
M&A news:
- HCHC +69.8% (announces BeneVir Biopharm to be acquired by Janssen Biotech).
Select AAPL related names showing strength:
- CRUS +3.2%, SWKS +1.9%, QRVO +1.5%, FNSR +1.1%, AVGO +0.7%, .
Other news:
- TRVN +10.5% (Trevana and Jiangsu Nhwa Pharma enter an exclusive license agreement for the development and commercialization of Trevena's investigational product oliceridine)
- SIGA +10.4% (SIGA Technologies announces a 'favorable' outcome of the FDA Antimicrobial Drugs Advisory Committee meeting on oral TPOXX)
- RGNX +2.2% (given FDA Fast Track designation for RGX-121 Gene Therapy)
- IAC +1.6% (following afternoon sell-off on FB dating app news)
- MTCH +1.5% (following afternoon sell-off on FB dating app news)
- PEP +0.9% (PepsiCo affirms increased dividend - previously announced increase in its annualized dividend)
Analyst comments:
- IRWD +1.9% (upgraded to Buy from Neutral at Mizuho)
- FCX +1.7% (upgraded to Sector Outperform at CIBC)
